![Robert Hurwitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Hurwitz is the founder of The Coral Co. which was founded in 1987.
He is currently the Chairman of BioMendics LLC and a Trustee at The MetroHealth System, Inc. where he started in 2017.
He was previously an Advisor at Edgewater Capital Partners.
Aktive Positionen von Robert Hurwitz
| Unternehmen | Position | Beginn |
|---|---|---|
The Coral Co.
 The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer | Gründer | 01.01.1987 |
The MetroHealth System, Inc.
 The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Direktor/Vorstandsmitglied | 01.01.2017 |
BioMendics LLC
 BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions | Vorsitzender | - |
Ehemalige bekannte Positionen von Robert Hurwitz
| Unternehmen | Position | Ende |
|---|---|---|
Edgewater Capital Partners
 Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Edgewater Capital Partners
Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million. | Finance |
The MetroHealth System, Inc.
The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
The Coral Co.
The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer | Finance |
BioMendics LLC
BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions | Health Technology |
Wählen Sie MarketScreener 
